Outset Medical, Inc. 8-K

What Happened
Outset Medical, Inc. (OM) filed an 8‑K on May 7, 2026 (Item 2.02) announcing it issued a press release and will hold its first-quarter 2026 earnings conference call to report financial results for the quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 to the filing.

Key Details

• Press release titled “Outset Medical Reports First-Quarter Results” dated May 7, 2026 (Exhibit 99.1).
• The company will hold an earnings conference call to discuss results for the quarter ended March 31, 2026.
• The 8‑K was signed by Renee Gaeta, Chief Financial Officer, on May 7, 2026.
• The filing (8‑K) furnishes the press release but does not include detailed financial statements within the 8‑K itself.

Why It Matters
This filing signals that Outset will publicly report its Q1 2026 earnings and management commentary—events that can affect the stock as investors react to revenue, profitability, and any guidance. Because the 8‑K references the press release (Exhibit 99.1) rather than embedding financial figures, investors should review the press release and listen to the earnings call for the actual numbers and management’s explanation.